NO990464D0 - Vaksinesammensetning mot malaria - Google Patents

Vaksinesammensetning mot malaria

Info

Publication number
NO990464D0
NO990464D0 NO990464A NO990464A NO990464D0 NO 990464 D0 NO990464 D0 NO 990464D0 NO 990464 A NO990464 A NO 990464A NO 990464 A NO990464 A NO 990464A NO 990464 D0 NO990464 D0 NO 990464D0
Authority
NO
Norway
Prior art keywords
vaccine composition
composition against
against malaria
malaria
vaccine
Prior art date
Application number
NO990464A
Other languages
English (en)
Other versions
NO990464L (no
NO319844B1 (no
Inventor
Joseph Cohen
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of NO990464D0 publication Critical patent/NO990464D0/no
Publication of NO990464L publication Critical patent/NO990464L/no
Publication of NO319844B1 publication Critical patent/NO319844B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
NO19990464A 1996-08-02 1999-02-01 Vaksinesammensetning og anvendelse derav NO319844B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9616351.4A GB9616351D0 (en) 1996-08-02 1996-08-02 Vaccine composition
PCT/EP1997/004326 WO1998005355A1 (en) 1996-08-02 1997-07-31 Vaccine composition against malaria

Publications (3)

Publication Number Publication Date
NO990464D0 true NO990464D0 (no) 1999-02-01
NO990464L NO990464L (no) 1999-02-01
NO319844B1 NO319844B1 (no) 2005-09-19

Family

ID=10797980

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19990464A NO319844B1 (no) 1996-08-02 1999-02-01 Vaksinesammensetning og anvendelse derav

Country Status (32)

Country Link
US (2) US20020172692A1 (no)
EP (2) EP1623720A3 (no)
JP (1) JP2000517295A (no)
KR (1) KR20000029747A (no)
CN (1) CN1241639C (no)
AP (1) AP1166A (no)
AR (1) AR008799A1 (no)
AT (1) ATE394119T1 (no)
AU (1) AU706303B2 (no)
BG (1) BG63290B1 (no)
BR (1) BR9710913A (no)
CA (1) CA2262402A1 (no)
CO (1) CO4650186A1 (no)
CZ (1) CZ290826B6 (no)
DE (1) DE69738672D1 (no)
DZ (1) DZ2283A1 (no)
EA (1) EA002167B1 (no)
GB (1) GB9616351D0 (no)
ID (1) ID17860A (no)
IL (1) IL128318A (no)
MA (1) MA24291A1 (no)
MY (1) MY116128A (no)
NO (1) NO319844B1 (no)
OA (1) OA10969A (no)
PE (1) PE97298A1 (no)
PL (1) PL188741B1 (no)
SK (1) SK282438B6 (no)
TR (1) TR199900195T2 (no)
UA (1) UA68336C2 (no)
UY (1) UY24654A1 (no)
WO (1) WO1998005355A1 (no)
ZA (1) ZA976815B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915204D0 (en) * 1999-06-29 1999-09-01 Smithkline Beecham Biolog Vaccine
PL376792A1 (pl) 2002-10-23 2006-01-09 Glaxosmithkline Biologicals S.A. Sposoby szczepienia przeciwko malarii
EP1690869B1 (en) * 2003-12-01 2010-02-24 Meiji Dairies Corporation Peptide inhibiting angiontensin converting enzyme
GB0513421D0 (en) 2005-06-30 2005-08-03 Glaxosmithkline Biolog Sa Vaccines
CN103690945A (zh) * 2005-08-02 2014-04-02 诺华疫苗和诊断有限公司 降低含油佐剂和含表面活性剂抗原之间的干扰
AU2007276217B2 (en) * 2006-07-18 2013-08-29 Glaxosmithkline Biologicals S.A. Vaccines for malaria
GB0614254D0 (en) * 2006-07-18 2006-08-30 Smithkline Beecham Biolog Vaccine
EA016417B1 (ru) 2006-09-07 2012-04-30 Глаксосмитклайн Байолоджикалс С.А. Способ получения вакцины
ES2658347T3 (es) 2007-08-13 2018-03-09 Glaxosmithkline Biologicals Sa Vacunas
CN102026657A (zh) * 2007-12-21 2011-04-20 葛兰素史密丝克莱恩生物有限公司 疟疾疫苗
BRPI0821531A2 (pt) * 2007-12-24 2015-06-16 Glaxosmithkline Biolog Sa Partícula de proteína imunogênica, composição farmacêutica, uso de uma partícula, método para tratar um paciente, hospedeiro, uso de um hospedeiro, processo para a produção de uma partícula, e, produto
EP2313108A4 (en) * 2008-06-30 2013-06-12 Us Army As Represented By The Secretary Of The Army ANTIPALUDE VACCINE OF SELF-ASSEMBLED POLYPEPTIDE NANOPARTICLES
EP3351266A1 (en) * 2009-11-05 2018-07-25 The United States of America as represented by the Secretary of the Navy Plasmodium falciparum sporozoite and liver stage antigens
US9168292B2 (en) 2010-09-27 2015-10-27 Crucell Holland B.V. Heterologous prime boost vaccination regimen against malaria
GB201116248D0 (en) 2011-09-20 2011-11-02 Glaxosmithkline Biolog Sa Liposome production using isopropanol
US20130122038A1 (en) 2011-11-14 2013-05-16 The United States Of America As Represented By The Secretary Of The Department Heterologous prime-boost immunization using measles virus-based vaccines
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
CN104338129B (zh) * 2013-07-26 2017-05-24 中国科学院上海巴斯德研究所 雷帕霉素作为疫苗佐剂的用途及制备方法
US10695424B2 (en) 2016-12-07 2020-06-30 Glaxosmithkline Biologicals S.A. Method of making a liposome composition
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
EP3630176A1 (en) 2017-05-30 2020-04-08 GlaxoSmithKline Biologicals S.A. Methods for manufacturing an adjuvant
JP2021504424A (ja) 2017-12-01 2021-02-15 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム サポニン精製
EP3980044A1 (en) 2019-06-05 2022-04-13 GlaxoSmithKline Biologicals SA Saponin purification

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0071705B1 (en) * 1981-05-21 1989-11-23 The Wellcome Foundation Limited Protozoal antigen
PT82282B (pt) * 1985-03-28 1988-02-17 Univ New York Processo de preparacao de um conjugado de proteina de suporte-antigeno imunogenico para uso como vacina contra malaria
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same
GB9012580D0 (en) * 1990-06-06 1990-07-25 Univ Nijmegen Novel protein
FR2679776A1 (fr) * 1991-07-31 1993-02-05 Pasteur Institut Melange de constituants peptidiques ayant des proprietes vaccinantes contre le paludisme, notamment du a plasmodium falciparum.
DE69228698T2 (de) * 1991-11-16 1999-09-16 Smithkline Beecham Biolog HYBRIDES PROTEIN ZWISCHEN CS AUS PLASMODIUM UND HBsAG
US6169171B1 (en) * 1992-02-27 2001-01-02 Smithkline Beecham Biologicals (S.A.) Hybrid protein between CS from plasmodium and HBSAG
EP0761231B1 (en) * 1992-06-25 2000-01-12 SMITHKLINE BEECHAM BIOLOGICALS s.a. Vaccine composition containing adjuvants
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
AUPM368994A0 (en) * 1994-02-04 1994-02-24 Saramane Pty Ltd Malaria merozoite antigen subunit vaccine
FR2744724B1 (fr) * 1996-02-14 2002-08-02 Pasteur Institut Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
FR2744723A1 (fr) * 1996-02-14 1997-08-14 Pasteur Institut Proteine recombinante contenant un fragment c-terminal d'une proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques

Also Published As

Publication number Publication date
PE97298A1 (es) 1999-02-14
IL128318A (en) 2002-04-21
EP0957933B1 (en) 2008-05-07
EP1623720A2 (en) 2006-02-08
CA2262402A1 (en) 1998-02-12
AU706303B2 (en) 1999-06-10
TR199900195T2 (xx) 1999-04-21
US20020172692A1 (en) 2002-11-21
NO990464L (no) 1999-02-01
SK282438B6 (sk) 2002-02-05
PL331424A1 (en) 1999-07-19
BG103141A (en) 1999-08-31
IL128318A0 (en) 2000-01-31
EP0957933A1 (en) 1999-11-24
EP1623720A3 (en) 2006-02-22
CO4650186A1 (es) 1998-09-03
OA10969A (en) 2003-03-04
ID17860A (id) 1998-01-29
PL188741B1 (pl) 2005-04-29
BR9710913A (pt) 1999-08-17
CN1231613A (zh) 1999-10-13
AU4204097A (en) 1998-02-25
GB9616351D0 (en) 1996-09-11
BG63290B1 (bg) 2001-09-28
EA199900069A1 (ru) 1999-10-28
US20060292170A1 (en) 2006-12-28
EA002167B1 (ru) 2002-02-28
AR008799A1 (es) 2000-02-23
AP9901448A0 (en) 1999-03-31
DZ2283A1 (fr) 2002-12-25
KR20000029747A (ko) 2000-05-25
UY24654A1 (es) 2001-08-27
CZ29299A3 (cs) 1999-06-16
MY116128A (en) 2003-11-28
SK11599A3 (en) 2000-03-13
CN1241639C (zh) 2006-02-15
NO319844B1 (no) 2005-09-19
WO1998005355A1 (en) 1998-02-12
UA68336C2 (en) 2004-08-16
ATE394119T1 (de) 2008-05-15
MA24291A1 (fr) 1998-04-01
CZ290826B6 (cs) 2002-10-16
JP2000517295A (ja) 2000-12-26
ZA976815B (en) 1998-05-11
AP1166A (en) 2003-06-30
DE69738672D1 (de) 2008-06-19

Similar Documents

Publication Publication Date Title
NO990464D0 (no) Vaksinesammensetning mot malaria
NO20003303L (no) Vaksine
BR9711853A (pt) Vacinas
NO20004758D0 (no) Vaksinesammensetning
NO996133D0 (no) Olje-i-vann-vaksinesammensetninger
PT1040051E (pt) Embalagem alveolar
DE69800383T2 (de) Influenza Vaccine
NO985460D0 (no) Limsammensetning
NO20006191D0 (no) Vaksine
ID20656A (id) Ko-produksi ester
IS5694A (is) Bóluefni
DE29706076U1 (de) Zahnmedizinischer Aufbaupfosten
DK1105498T3 (da) HIV vaccine
DE29720848U1 (de) Zugsäge
NL300165I2 (nl) Babesiavaccin.
ID23663A (id) Persiapan kaprolaktam
DE29601005U1 (de) Fassade
IT1294969B1 (it) Composizione immunogena per hiv
DE9408070U1 (de) Lösespitze
HUP9902885A3 (en) Vaccine compositions against malaria
BR1100918A (pt) Composição de vacina contendo adjuvantes
ITMI981384A0 (it) Vaccino per hiv
BR9603049A (pt) Inércia
FI941159A0 (fi) Mot nedrinning skyddad pinngaongstegel
KR970058595U (ko) 자의 눈금이 있는 흙손